Literature DB >> 12108877

Acute adrenal crisis in asthmatics treated with high-dose fluticasone propionate.

G R G Todd1, C L Acerini, J J Buck, N P Murphy, R Ross-Russell, J T Warner, D R McCance.   

Abstract

Four cases of asthma (one adult, three children) developing acute adrenal crisis after introduction of high-dose inhaled fluticasone proprionate are presented. The three children, aged 7-9 yrs, had been prescribed inhaled fluticasone, dosage 500-2,000 microg x day(-1) and duration 5 months-5 yrs. All presented with convulsions due to hypoglycaemia (blood glucose 1.3-1.8 mM). The fourth case was a male of 33 yrs with difficult-to-control asthma and had been taking fluticasone propionate 1,000-2,000 microg x day(-1) for 3 yrs. He presented with fatigue, lethargy, nausea and postural hypotension. Acute adrenal crisis in each case was confirmed by investigations which included measurement of acute phase cortisol levels, short and long Synacthen stimulation tests and glucagon stimulation tests. Other cases of hypthoalamic-pituitary-adrenal axis suppression were excluded.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12108877     DOI: 10.1183/09031936.02.00274402

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  25 in total

Review 1.  The dose-response relationship of inhaled corticosteroids in asthma.

Authors:  Matthew Masoli; Shaun Holt; Mark Weatherall; Richard Beasley
Journal:  Curr Allergy Asthma Rep       Date:  2004-03       Impact factor: 4.806

2.  Concurrent oral and inhalation drug delivery using a dual formulation system: the use of oral theophylline carrier with combined inhalable budesonide and terbutaline.

Authors:  Rania O Salama; Paul M Young; Daniela Traini
Journal:  Drug Deliv Transl Res       Date:  2014-06       Impact factor: 4.617

3.  Systematic review: adrenal insufficiency secondary to swallowed topical corticosteroids in eosinophilic oesophagitis.

Authors:  H Philpott; M K Dougherty; C C Reed; M Caldwell; D Kirk; D J Torpy; E S Dellon
Journal:  Aliment Pharmacol Ther       Date:  2018-03-05       Impact factor: 8.171

Review 4.  Safety of the newer inhaled corticosteroids in childhood asthma.

Authors:  Tabitha L Randell; Kim C Donaghue; Geoffrey R Ambler; Christopher T Cowell; Dominic A Fitzgerald; Peter P van Asperen
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 5.  Systematic review of the dose-response relation of inhaled fluticasone propionate.

Authors:  M Masoli; M Weatherall; S Holt; R Beasley
Journal:  Arch Dis Child       Date:  2004-10       Impact factor: 3.791

6.  Lost in the mist: acute adrenal crisis following intranasal fluticasone propionate overuse.

Authors:  Arturo Loaiza-Bonilla; Tollin Sullivan; Ryan Kendall Harris
Journal:  Case Rep Med       Date:  2010-08-30

7.  Inhaled corticosteroids and adrenal insufficiency: prevalence and clinical presentation.

Authors:  Mathieu Molimard; Pierre-Olivier Girodet; Clothilde Pollet; Annie Fourrier-Réglat; Amélie Daveluy; Françoise Haramburu; Michaël Fayon; Antoine Tabarin
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

8.  Monitoring growth in asthmatic children treated with high dose inhaled glucocorticoids does not predict adrenal suppression.

Authors:  K A Dunlop; D J Carson; H J Steen; V McGovern; J McNaboe; M D Shields
Journal:  Arch Dis Child       Date:  2004-08       Impact factor: 3.791

Review 9.  Inhaled corticosteroids, bone mineral density and fracture in older people.

Authors:  Richard Hubbard; Anne Tattersfield
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

10.  Fluticasone propionate in asthma: a long term dose comparison study.

Authors:  E Verona; D Petrov; E Cserhati; J Hofman; N Geppe; H Medley; S Hughes
Journal:  Arch Dis Child       Date:  2003-06       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.